Pharmaceuticals, Biotechnology and Life Sciences
Onzima Ventures said on Tuestday it would buy another 51% of N4 Pharma Limited shares with 34609210 new ordinary shares of of 0.1p each in its capital. The acquisition should be completed by mid-April 2017.
Pure-play aesthetics company SInclair Pharma has reported topping out market expectations with sales in the twelve months until December 2016 being about £2m, which represents the gorwth of more than 37% to £37.8m.
Novo Nordisk has initiated a share repurchase programme in accordance with certain European regulations known as the Safe Harbour rules.
Hutchison China MediTech has appointed Paul Rutherford Carter as its Senior Independent Non-Executive Director, and a member of several its…
ConvaTec Group, a UK-based medical products and technologies company, said on Monday that it has appointed two joint corporate brokers.
Mainstay Medical International’s subsidiary Mainstay Medical Limited (MML) has made a new supply deal with Centro de Construccion de Cardioestimuladores del Uruguay S.A. (CCC)
Creso Pharma Limited, the company that Creso Pharma, the company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy and Bracknor Investment,…
AIM and Nasdaq listed pharmaceutical company, Hutchison China MediTech Limited (Chi-Med) has initiated two Phase II studies in China for testing cancer treatments.
University of Michigan Pancreatic Cancer Center has become the most recent member of the global network of prominent sites participating…